In yesterday’s Wall Street session, Moderna Inc (NASDAQ:MRNA) shares traded at $39.51, up 7.22% from the previous session.
MRNA stock price is now -31.67% away from the 50-day moving average and -59.39% away from the 200-day moving average. The market capitalization of the company currently stands at $14.09B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target maintained at $58, HSBC Securities recently Upgraded its rating from Hold to Buy for Moderna Inc (NASDAQ: MRNA). On November 15, 2024, Wolfe Research recently initiated its ‘Underperform’ rating on the stock quoting a target price of $40, while ‘Bernstein’ rates the stock as ‘Mkt Perform’
In other news, Hoge Stephen, President sold 277 shares of the company’s stock on Nov 11 ’24. The stock was sold for $12,771 at an average price of $46.10. Upon completion of the transaction, the President now directly owns 1,443,248 shares in the company, valued at $57.02 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 11 ’24, Officer Hoge Stephen bought 277 shares of the business’s stock. A total of $12,771 was incurred on buying the stock at an average price of $46.10. A total of 10.83% of the company’s stock is owned by insiders.
During the past 12 months, Moderna Inc has had a low of $35.80 and a high of $170.47. As of last week, the company has a debt-to-equity ratio of 0.11, a current ratio of 4.39, and a quick ratio of 4.20. The fifty day moving average price for MRNA is $58.5626 and a two-hundred day moving average price translates $97.57143 for the stock.
The latest earnings results from Moderna Inc (NASDAQ: MRNA) was released for 2024-09-30. The net profit margin was -43.84% and return on equity was -17.52% for MRNA. The company reported revenue of $1.86 billion for the quarter, compared to $1.83 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 1.69 percent.
